retatrutide clinical trials phase 2 Obesity is expected to affect nearly a quarter of the world population by 2035. Retatrutide, an investigational GIP, GLP-1, and GCG receptor agonist, holds promise for weight reduction in adults. New How to Get Retatrutide in
Pay in 4 interest-free payments of $5.50 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 21 - Oct 26

00092-0/asset/68240365-3bb7-461d-91f9-d644c6b9c749/main.assets/gr3.jpg)






















